- Home
- BRNX vs BDRX Comparison
BRNX vs BDRX Comparison
Compare BRNX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRNX | BDRX |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.6M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BRNX | BDRX |
|---|---|---|
| Price | $0.42 | $2.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 67.2K | ★ 1.0M |
| Earning Date | 09-09-2026 | 09-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35,081.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.34 |
| 52 Week High | $10.36 | $8.94 |
Technical Indicators
Market Signals| Indicator | BRNX | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 25.73 | 58.09 |
| Support Level | $0.41 | $0.70 |
| Resistance Level | $2.49 | $3.50 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 1.17 | 53.86 |
Price Performance
Historical ComparisonAbout BRNX BrenX Ltd. Ordinary Shares
BrenX Ltd is reshaping industrial energy to make it cleaner, more reliable, and lower cost. Building on its proprietary bGen thermal energy storage technology, which converts electricity and recovered heat into dispatchable energy, BrenX develops, owns, operates, and optimizes energy assets that serve industrial customers and data centers. From local generation and storage to grid connectivity and intelligent energy management, BrenX brings together technologies and infrastructure to create complete energy platforms around customer needs, with flexible energy assets designed to meet growing energy demand.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.